The majority (95%) of causative mutations underlying NPC have been identified in NPC1 (NPC1 disease, OMIM #257220), while the remaining 5% are located in NPC2 (NPC2 disease, OMIM #607625) [1,3,4]. Here, NPC2 is linked to nasopharyngeal carcinoma.